Shares of Moderna Inc (MRNA) have moved above the average 12-month price target set by analysts, reaching $141.04 per share in recent...
SHANGHAI, CHINA — June 9, 2026: The global race for brain–computer interface (BCI) dominance has intensified with a landmark Chinese funding round....
In a innovative move that merges state-of-the-art biotechnology with digital asset strategy, Propanc Biopharma’s $100 million Ethereum allocation represents one of the...